2 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
Follow Central Retinal Vein Occlusion: new trials by email Literature Review of Central Retinal Vein Occlusion trials Research Report on Central Retinal Vein Occlusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I ziv-aflibercept drug - Age Related Macular Degeneration, Central Retinal Vein Occlusion | Phase 1 | Unknown | Rafic Hariri University Hospital | 100 | 2014-06-01 | 2014-06-25 |
| Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion ranibizumab (Lucentis) - Venous Retinal Branch Occlusion, Central Retinal Vein Occlusion | Phase 1 | Unknown | Retina Associates of Cleveland, Inc | 45 | 2009-11-01 | 2011-03-18 |
Retinal Vein Occlusion (2) · Depression (1) · Macular Degeneration (1)
Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Eye Diseases (2) · Retinal Diseases (2) · Thrombosis (2) · Vascular Diseases (2) · Venous Thrombosis (2) · Behavior (1) · Behavioral Symptoms (1) · Retinal Degeneration (1)
Ranibizumab (1) · aflibercept (1)
Rafic Hariri University Hospital (1) · Retina Associates of Cleveland, Inc (1)
Lebanon (1) · United States (1)
Ahmad Mansour, MD (1) · Lawrence J Singerman, MD (1)